
Venor Pharma Limited
Pharmaceutical company that trades, manufactures, and distributes various products such as syrups, tablets, and injections.
Pharmaceutical company that trades, manufactures, and distributes various products such as syrups, tablets, and injections.
Venor Pharma Limited (VPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 03 May 2013 and has a history of 11 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹49.58 Cr.
Vishwas Verma, Savita Verma, Shubham Verma, and Three other members serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74900DL2013PLC251565
251565
Public Limited Indian Non-Government Company
03 May 2013
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishwas Verma ![]() | Director | 03-May-2013 | Current |
Savita Verma ![]() | Director | 03-May-2013 | Current |
Shubham Verma ![]() | Director | 31-Aug-2018 | Current |
Ritesh Khetarpal | Director | 01-Jun-2024 | Current |
Shivam Verma ![]() | Director | 24-May-2023 | Current |
Yogesh Kapoor ![]() | Director | 08-Feb-2023 | Current |
Venor Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.74% increase. The company also saw a substantial improvement in profitability, with a 66.15% increase in profit. The company's net worth Soared by an impressive increase of 125.03%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Venor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shubham Verma is a mutual person
Vishwas Verma, Savita Verma and 1 more are mutual person
Savita Verma and Shubham Verma are mutual person
₹49.58 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
11 May 2023 | Others | ₹15.00 Cr | Open |
20 Dec 2022 | Hdfc Bank Limited | ₹21.60 Cr | Open |
02 Aug 2022 | Others | ₹12.98 Cr | Open |
Venor Pharma has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Venor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venor Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Venor Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ritesh Khetarpal was appointed as a Director was appointed as a Director on 01 Jun 2024 & has been associated with this company since 9 months 14 days .
A charge with Hdfc Bank Limited of Rs. 21.60 Cr registered on 20 Dec 2022 with Charge ID 100709156 was modified on 29 May 2024.
Venor Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Shivam Verma was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 1 year 9 months .
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100715044 was registered on 11 May 2023.
Venor Pharma Limited was incorporated on 03 May 2013.
The authorized share capital of Venor Pharma Limited is ₹ 5.00 Cr and paid-up capital is ₹ 1.00 M.
Currently 6 directors are associated with Venor Pharma Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Venor Pharma Limited is A - 43 Ground Floor, G. T. Karnal Road Industrial Area India, Delhi, 110033.
The corporate identification number (CIN) of Venor Pharma Limited is U74900DL2013PLC251565 and the company number is 251565 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Venor Pharma Limited has risen by 18.74%.
As Per 2023 financial reports, 170 employees are currently employed by Venor Pharma Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Venor Pharma Limited has experienced an upsurge of 125.03%.
As per the financial statements for fiscal Year 2023, The total open charges for Venor Pharma Limited amount to ₹ 49.58 Cr.
The most recent Balance Sheet for Venor Pharma Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
PV
KM
VV